Impact of a Mobile Health System on the Suppression of Schistosoma haematobium in Chad.

Abstract

This study determined the contribution of a mobile health (M-health) system to the treatment of Schistosoma haematobium in a region of Chad where S. haematobium is endemic. M-health involves the use of a mobile phone for health care. The study compared the prevalence of schistosomiasis in an area with an M-health system, newly installed in 2014, with an area without an adequate health infrastructure. Data were gathered after the M-health system had been running for 3 years. We took urine samples from children age 1 to 15 years, for a total of 200 children in a village in the M-health area and 200 in a village in a non-M-health area. Urine was checked for urinary schistosomiasis by using dipsticks for microhematuria and, in cases of positive dipstick results, microscopy was used to detect eggs. Comparison between the areas allowed us to assess the effectiveness of the installed M-health system after 3 years of operation. Based on dipstick outcomes, the non-M-health area had an infection rate of 51.5% compared with 29% in the M-health area. Microscopy results in non-M-health and M-health were 27.5% and 21%, respectively. The dipstick result difference between M-health and non-M-health areas was statistically significant. Dipsticks were more reliable than microscopy for the detection of schistosomiasis, especially in areas without qualified personnel. Based on these results, M-health proved its ability to reduce the infection rate of urogenital schistosomiasis, and the implementation of M-health shows great promise in areas where this disease is endemic and where no mass drug administration is provided.

• Authors: Didier Lalaye, Mirjam E de Bruijn, Tom P V M de Jong
• Journal: The American journal of tropical medicine and hygiene (Am J Trop Med Hyg) Vol. 105 Issue 4 Pg. 1104-1108 (08 16 2021) ISSN: 1476-1645 [Electronic] United States
• PMID: 34398817 (Publication Type: Journal Article)

Chemical References

• Anthelmintics
• Praziquantel

Topics

• Adolescent
• Animals
• Anthelmintics (therapeutic use)
• Chad (epidemiology)
• Child
• Child, Preschool
• Female
• Humans
• Infant
• Male
• Mobile Health Units
• Praziquantel (therapeutic use)
• Schistosoma haematobium
• Schistosomiasis haematobia (drug therapy, epidemiology)